RU2198164C2 - N1-[2,2-диметил-1s-(пиридин-2-илкарбамоил)пропил]-n4-гидрок си-2r-изобутил-3s-метоксисукцинамид или его фармацевтически приемлемая соль, гидрат или сольват - Google Patents

N1-[2,2-диметил-1s-(пиридин-2-илкарбамоил)пропил]-n4-гидрок си-2r-изобутил-3s-метоксисукцинамид или его фармацевтически приемлемая соль, гидрат или сольват Download PDF

Info

Publication number
RU2198164C2
RU2198164C2 RU2000114634/04A RU2000114634A RU2198164C2 RU 2198164 C2 RU2198164 C2 RU 2198164C2 RU 2000114634/04 A RU2000114634/04 A RU 2000114634/04A RU 2000114634 A RU2000114634 A RU 2000114634A RU 2198164 C2 RU2198164 C2 RU 2198164C2
Authority
RU
Russia
Prior art keywords
compound
alkyl
dimethyl
isobutyl
hydroxy
Prior art date
Application number
RU2000114634/04A
Other languages
English (en)
Russian (ru)
Other versions
RU2000114634A (ru
Inventor
Рэймонд Пол БЕКЕТТ
Марк Уиттакер
Эндрю Миллер
Фионна Митчелл МАРТИН
Original Assignee
Бритиш Биотех Фармасьютикалс Лимитед
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Бритиш Биотех Фармасьютикалс Лимитед filed Critical Бритиш Биотех Фармасьютикалс Лимитед
Publication of RU2000114634A publication Critical patent/RU2000114634A/ru
Application granted granted Critical
Publication of RU2198164C2 publication Critical patent/RU2198164C2/ru

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/75Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4402Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Lubricants (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Saccharide Compounds (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
RU2000114634/04A 1997-11-13 1997-11-13 N1-[2,2-диметил-1s-(пиридин-2-илкарбамоил)пропил]-n4-гидрок си-2r-изобутил-3s-метоксисукцинамид или его фармацевтически приемлемая соль, гидрат или сольват RU2198164C2 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/GB1997/003132 WO1999025693A1 (en) 1997-11-13 1997-11-13 Metalloproteinase inhibitors

Publications (2)

Publication Number Publication Date
RU2000114634A RU2000114634A (ru) 2002-07-10
RU2198164C2 true RU2198164C2 (ru) 2003-02-10

Family

ID=10807699

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2000114634/04A RU2198164C2 (ru) 1997-11-13 1997-11-13 N1-[2,2-диметил-1s-(пиридин-2-илкарбамоил)пропил]-n4-гидрок си-2r-изобутил-3s-метоксисукцинамид или его фармацевтически приемлемая соль, гидрат или сольват

Country Status (21)

Country Link
EP (1) EP1030842B1 (US06559137-20030506-C00039.png)
JP (1) JP2001523666A (US06559137-20030506-C00039.png)
KR (1) KR100485479B1 (US06559137-20030506-C00039.png)
AT (1) ATE236126T1 (US06559137-20030506-C00039.png)
AU (1) AU740420B2 (US06559137-20030506-C00039.png)
BR (1) BR9714934A (US06559137-20030506-C00039.png)
CA (1) CA2310593C (US06559137-20030506-C00039.png)
DE (1) DE69720554T2 (US06559137-20030506-C00039.png)
DK (1) DK1030842T3 (US06559137-20030506-C00039.png)
ES (1) ES2195122T3 (US06559137-20030506-C00039.png)
GB (1) GB2333524A (US06559137-20030506-C00039.png)
HU (1) HUP0002811A3 (US06559137-20030506-C00039.png)
IL (1) IL135210A0 (US06559137-20030506-C00039.png)
NO (1) NO315702B1 (US06559137-20030506-C00039.png)
NZ (1) NZ503642A (US06559137-20030506-C00039.png)
PL (1) PL189542B1 (US06559137-20030506-C00039.png)
PT (1) PT1030842E (US06559137-20030506-C00039.png)
RU (1) RU2198164C2 (US06559137-20030506-C00039.png)
TR (1) TR200001353T2 (US06559137-20030506-C00039.png)
TW (1) TW474919B (US06559137-20030506-C00039.png)
WO (1) WO1999025693A1 (US06559137-20030506-C00039.png)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20030701A1 (es) 2001-12-20 2003-08-21 Schering Corp Compuestos para el tratamiento de trastornos inflamatorios

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1049651C (zh) * 1994-01-20 2000-02-23 英国生物技术药物有限公司 金属蛋白酶抑制剂
WO1997003966A1 (en) * 1995-07-19 1997-02-06 British Biotech Pharmaceuticals Limited N-(amino acid) substituted succinic acid amide derivatives as metalloproteinase inhibitors

Also Published As

Publication number Publication date
NO315702B1 (no) 2003-10-13
ES2195122T3 (es) 2003-12-01
GB2333524A (en) 1999-07-28
DK1030842T3 (da) 2003-07-28
BR9714934A (pt) 2000-10-03
EP1030842B1 (en) 2003-04-02
CA2310593C (en) 2007-05-08
AU4958497A (en) 1999-06-07
NZ503642A (en) 2001-10-26
HUP0002811A2 (hu) 2001-01-29
PT1030842E (pt) 2003-07-31
ATE236126T1 (de) 2003-04-15
IL135210A0 (en) 2001-05-20
EP1030842A1 (en) 2000-08-30
NO20002480L (no) 2000-05-12
DE69720554D1 (de) 2003-05-08
JP2001523666A (ja) 2001-11-27
CA2310593A1 (en) 1999-05-27
KR100485479B1 (ko) 2005-04-27
TW474919B (en) 2002-02-01
KR20010031879A (ko) 2001-04-16
TR200001353T2 (tr) 2000-10-23
AU740420B2 (en) 2001-11-01
HUP0002811A3 (en) 2002-11-28
PL340494A1 (en) 2001-02-12
DE69720554T2 (de) 2004-01-08
PL189542B1 (pl) 2005-08-31
WO1999025693A1 (en) 1999-05-27
GB9816317D0 (en) 1998-09-23
NO20002480D0 (no) 2000-05-12

Similar Documents

Publication Publication Date Title
KR100418808B1 (ko) 금속단백질분해효소억제제
US7148198B2 (en) Antibacterial agents
US7126001B2 (en) Class of cytodifferentiating agents and histone deacetylase inhibitors, and methods of use thereof
JP4070955B2 (ja) 置換2−アミノアセトアミドおよびその使用
KR100352316B1 (ko) 메탈로프로테아제억제제로서사용되는술포닐아미노치환히드록삼산유도체
JP5340918B2 (ja) p38MAPキナーゼ阻害剤
CN101820848A (zh) 抑制n-酰基乙醇胺水解性酸酰胺酶的组合物和方法
JP2002541197A (ja) 抗菌剤
US11701370B2 (en) Phosphonium ion channel blockers and methods for use
US6846825B1 (en) Antibacterial agents
CA2296560C (en) Amino acid derivatives useful to treat stroke
RU2198164C2 (ru) N1-[2,2-диметил-1s-(пиридин-2-илкарбамоил)пропил]-n4-гидрок си-2r-изобутил-3s-метоксисукцинамид или его фармацевтически приемлемая соль, гидрат или сольват
EP1146867B1 (en) Antibacterial hydroxamic acid derivatives
US6476067B1 (en) N-formyl hydroxylamine derivatives as antibacterial agents
US20090069322A1 (en) N-formyl hydroxylamine derivatives as inhibitors of bacterial polypeptide formylase for treating microbial infections
US20040102491A1 (en) Antimicrobial agents
MXPA00004642A (en) Metalloproteinase inhibitors
CN1125050C (zh) 金属蛋白酶抑制剂
ZA200201093B (en) Antibacterial agents.

Legal Events

Date Code Title Description
MM4A The patent is invalid due to non-payment of fees

Effective date: 20071114